Sarepta Therapeutics Announces Favorable USPTO Decisions in Exon 51 and Exon 53 Composition of Matter Patent Interference Cases against BioMarin Pharmaceutical

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/24/2026

1. SPCX
2. META
3. ABBV
4. SPY
5. FDX
6. IBM
7. NKE
8. MU
9. PFE
10. AWK

Go back to Sarepta Therapeutics Announces Favorable USPTO Decisions in Exon 51 and Exon 53 Composition of Matter Patent Interference Cases against BioMarin Pharmaceutical
SAREPTA THERAP (NASDAQ: SRPT) Delayed: 17.26 -0.39 (2.21%)
Previous Close $17.65    52 Week High $63.73 
Open $17.33    52 Week Low $8.00 
Day High $17.80    P/E N/A 
Day Low $17.22    EPS $-5.69 
Volume 2,371,201